摘要
文章从两方面综述拉米夫定与其他药物联合治疗慢性乙型肝炎 ,一方面与西药联合应用 ,另一方面与中药联合应用。拉米夫定与其他药物联合治疗的方法比拉米夫定单独治疗慢性乙型肝炎有效。联合疗法将成为治疗慢性乙型肝炎的趋势 ,其中重要的是中药复方制剂具有针对多靶位起效的优势 ,与拉米夫定联合应用可以缩短疗程和降低疾病复发率 ,可见中西药联合应用治疗慢性乙型肝炎有显著的优势及广阔的发展前景。
This paper summarized the effects of the t reatment of chronic hepatitis B (CHB) by lamivudine combined with traditional Ch inese medicine or western medicine in the past few years. Combined treatment of lamivudine and the other medicine had higher efficiency than lamvudine alone in the treatment of CHB. The Combined treatment should be a tendency of the treatme nt for chronic hepatitis B. The focal point is that the traditional Chinese reci pe produces a multitarget effect in the treatment of CHB. The combined treatment of lamivudine and traditional Chinese recipe can reduce the treatment course an d the recurrence rate. Combined treatment of traditional Chinese medicine and we stern medicine has notable superiority and broad developing prospect in the trea tment of CHB.
出处
《中西医结合学报》
CAS
2003年第2期146-150,共5页
Journal of Chinese Integrative Medicine
